The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases
Open accessAbstract
Ferroptosis is a kind of regulated cell death (RCD) caused by the redox state disorder of intracellular microenvironment controlled by glutathione (GSH) peroxidase 4 (GPX4), which is inhibited by iron chelators and lipophilic antioxidants. In addition to classical regulatory mechanisms, new regulatory factors for ferroptosis have been discovered in recent years, such as the P53 pathway, the activating transcription factor (ATF)3/4 pathway, Beclin 1 (BECN1) pathway, and some non-coding RNA. Ferroptosis is closely related to cancer treatment, neurodegenerative diseases, ischemia-reperfusion of organ, neurotoxicity, and others, in particular, in the field of neurodegenerative diseases treatment has aroused people's interest. The nuclear factor E2 related factor 2 (Nrf2/NFE2L2) has been proved to play a key role in neurodegenerative disease treatment and ferroptosis regulation. Ferroptosis promotes the progression of neurodegenerative diseases, while the expression of Nrf2 and its target genes (Ho-1, Nqo-1, and Trx) has been declined with aging; therefore, there is still insufficient evidence for ferroptosis and Nrf2 regulatory networks in the field of neurodegenerative diseases. In this review, we will provide a brief overview of ferroptosis regulatory mechanisms, as well as an emphasis on the mechanism of Nrf2 regulating ferroptosis. We also highlight the role of ferroptosis and Nrf2 during the process of neurodegenerative diseases and investigate a theoretical basis for further research on the relationship between Nrf2 and ferroptosis in the process of neurodegenerative diseases treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Muhammad, T., Ikram, M., Ullah, R., Rehman, S., & Kim, M. (2019) · Nutrients · doi:10.3390/nu11030648 · Cited by 443
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · cited 1×
“…defined ferroptosis as a form of regulated cell death (RCD) caused by oxidative alterations in the intracellular microenvironment controlled by glutathione (GSH) peroxidase 4 (GPX4) constitutively, and it can be inhibited by iron chelators and lipophilic antioxidants (Galluzzi et al., 2018).”
BackgroundACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
FSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Kagan, V. E., Mao, G., Qu, F., Angeli, J. P. F., Doll, S., Croix, C. S., Dar, H. H., Liu, B., Tyurin, V. A., Ritov, V. B., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2238 · Cited by 3,029
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Dodson, M., Castro-Portuguez, R., & Zhang, D. D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101107 · Cited by 2,435
Autophagy promotes ferroptosis by degradation of ferritin
Hou, W., Xie, Y., Song, X., Sun, X., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2016) · Autophagy · doi:10.1080/15548627.2016.1187366 · Cited by 2,332
Self-citationTranscriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,192
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Ferroptosis as a target for protection against cardiomyopathy
Fang, X., Wang, H., Han, D., Xie, E., Yang, X., Wei, J., Gu, S., Gao, F., Zhu, N., Yin, X., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821022116 · Cited by 2,127
Role of Mitochondria in Ferroptosis
Gao, M., Yi, J., Zhu, J., Minikes, A. M., Monian, P., Thompson, C. B., & Jiang, X. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.10.042 · Cited by 2,120
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W., & Kimmelman, A. C. (2014) · Nature · doi:10.1038/nature13148 · Cited by 2,084
Glutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069 · cited 1×
“In addition to the final key morphological changes, the increase of free iron and lipid peroxidation are also important features of ferroptosis, and it is also related to the instability of the plasma membrane, disrupted protein stability, and cytoskeleton rearrangement, leading to the obvious “balloon” phenotype of t…”
BackgroundSun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012
Ferroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899
Lipid peroxidation in cell death
Gaschler, M. M., & Stockwell, B. R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.086 · Cited by 1,828
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735 · cited 1×
“…electron-dense mass formation Frontiers in Neuroscience | www.frontiersin.org 1 April 2020 | Volume 14 | Article 267 under ultrastructure, reduction or disappearance of mitochondrial cristae, changes in membrane potential, and rupture of mitochondria outer membrane (Vanden Berghe et al., 2014).”
BackgroundSelenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis
Ingold, I., Berndt, C., Schmitt, S., Doll, S., Poschmann, G., Buday, K., Roveri, A., Peng, X., Porto Freitas, F., Seibt, T., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.048 · Cited by 1,656
Toxicity of iron and hydrogen peroxide: the Fenton reaction
Winterbourn, C. C. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03532-x · Cited by 1,415
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S.-C., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,254
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,086
Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., Liao, P., Zhou, J., Zhang, Q., Dow, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0338 · Cited by 1,047
Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death
Dixon, S. J., Winter, G. E., Musavi, L. S., Lee, E. D., Snijder, B., Rebsamen, M., Superti-Furga, G., & Stockwell, B. R. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00245 · Cited by 1,043
GPX4 at the crossroads of lipid homeostasis and ferroptosis
Forcina, G. C., & Dixon, S. J. (2019) · PROTEOMICS · doi:10.1002/pmic.201800311 · Cited by 1,025
Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis
Shimada, K., Skouta, R., Kaplan, A., Yang, W. S., Hayano, M., Dixon, S. J., Brown, L. M., Valenzuela, C. A., Wolpaw, A. J., & Stockwell, B. R. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2079 · Cited by 1,017
Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke
Alim, I., Caulfield, J. T., Chen, Y., Swarup, V., Geschwind, D. H., Ivanova, E., Seravalli, J., Ai, Y., Sansing, L. H., Ste.Marie, E. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.032 · Cited by 999
The selenoenzyme phospholipid hydroperoxide glutathione peroxidase
Ursini, F., Maiorino, M., & Gregolin, C. (1985) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(85)90182-5 · Cited by 990
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
Self-citationPEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals
Wenzel, S. E., Tyurina, Y. Y., Zhao, J., St. Croix, C. M., Dar, H. H., Mao, G., Tyurin, V. A., Anthonymuthu, T. S., Kapralov, A. A., Amoscato, A. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.044 · Cited by 950
Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease
Bogdan, A. R., Miyazawa, M., Hashimoto, K., & Tsuji, Y. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.11.012 · Cited by 893
ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway
Chu, B., Kon, N., Chen, D., Li, T., Liu, T., Jiang, L., Song, S., Tavana, O., & Gu, W. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0305-6 · Cited by 882
Li, Y., Feng, D., Wang, Z., Zhao, Y., Sun, R., Tian, D., Liu, D., Zhang, F., Ning, S., Yao, J., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0299-4 · Cited by 872
ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–
Wang, L., Liu, Y., Du, T., Yang, H., Lei, L., Guo, M., Ding, H.-F., Zhang, J., Wang, H., Chen, X., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0380-z · Cited by 809
Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses
Ou, Y., Wang, S.-J., Li, D., Chu, B., & Gu, W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607152113 · Cited by 765
Dowdle, W. E., Nyfeler, B., Nagel, J., Elling, R. A., Liu, S., Triantafellow, E., Menon, S., Wang, Z., Honda, A., Pardee, G., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3053 · Cited by 759 · cited 1×
“When iron homeostasis in the body is out of balance, autophagy of ferritin (namely, ferritinophagy) mediated by nuclear receptor coactivator 4 (NCOA4) releases iron bounds to ferritin (Kruer, 2013; Dowdle et al., 2014; Mancias et al., 2014; Gao et al., 2016) or an abnormal increase in labile iron pools (LIP) through d…”
BackgroundUnsolved mysteries: How does lipid peroxidation cause ferroptosis?
Feng, H., & Stockwell, B. R. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006203 · Cited by 759
Furukawa, M., & Xiong, Y. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.162-171.2005 · Cited by 746
The Roles of NRF2 in Modulating Cellular Iron Homeostasis
Kerins, M. J., & Ooi, A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7176 · Cited by 738
Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis
Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28574 · Cited by 703
The tumor suppressor protein p53 and the ferroptosis network
Kang, R., Kroemer, G., & Tang, D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.074 · Cited by 698
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
Do Van, B., Gouel, F., Jonneaux, A., Timmerman, K., Gelé, P., Pétrault, M., Bastide, M., Laloux, C., Moreau, C., Bordet, R., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.011 · Cited by 689
Current understanding of iron homeostasis
Anderson, G. J., & Frazer, D. M. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.155804 · Cited by 688
The release and activity of HMGB1 in ferroptosis
Wen, Q., Liu, J., Kang, R., Zhou, B., & Tang, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.090 · Cited by 672
Gureev, A. P., Shaforostova, E. A., & Popov, V. N. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00435 · Cited by 643
Andrews, N. C., & Schmidt, P. J. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.164337 · Cited by 642
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
Hassannia, B., Wiernicki, B., Ingold, I., Qu, F., Van Herck, S., Tyurina, Y. Y., Bayır, H., Abhari, B. A., Angeli, J. P. F., Choi, S. M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99032 · Cited by 627
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
Devos, D., Moreau, C., Devedjian, J. C., Kluza, J., Petrault, M., Laloux, C., Jonneaux, A., Ryckewaert, G., Garçon, G., Rouaix, N., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5593 · Cited by 619
Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Louandre, C., Ezzoukhry, Z., Godin, C., Barbare, J., Mazière, J., Chauffert, B., & Galmiche, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28159 · Cited by 602
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells
Zhu, S., Zhang, Q., Sun, X., Zeh, H. J., Lotze, M. T., Kang, R., & Tang, D. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1979 · Cited by 576
Ferroptosis Inhibition: Mechanisms and Opportunities
Angeli, J. P. F., Shah, R., Pratt, D. A., & Conrad, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.02.005 · Cited by 563
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Tarangelo, A., Magtanong, L., Bieging-Rolett, K. T., Li, Y., Ye, J., Attardi, L. D., & Dixon, S. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.077 · Cited by 554
Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death
Tesfay, L., Paul, B. T., Konstorum, A., Deng, Z., Cox, A. O., Lee, J., Furdui, C. M., Hegde, P., Torti, F. M., & Torti, S. V. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0369 · Cited by 551
Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer
Shin, D., Kim, E. H., Lee, J., & Roh, J.-L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.426 · Cited by 534
Wang, M., Mao, C., Ouyang, L., Liu, Y., Lai, W., Liu, N., Shi, Y., Chen, L., Xiao, D., Yu, F., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0304-y · Cited by 534
Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis
Chang, L.-C., Chiang, S.-K., Chen, S.-E., Yu, Y.-L., Chou, R.-H., & Chang, W.-C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.12.025 · Cited by 521
CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation
Yuan, H., Li, X., Zhang, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.034 · Cited by 504
The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11
Liu, T., Jiang, L., Tavana, O., & Gu, W. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3037 · Cited by 490
Melatonin and inflammation-Story of a double-edged blade
Hardeland, R. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12525 · Cited by 455 · cited 1×
“Meanwhile, MLT is also known to regulate fundamental cellular functions by exhibiting antioxidant, antiaging, antivenom, oncostatic, cytoprotective, and immunomodulatory activities (Hardeland, 2018).”
BackgroundBrissot, P., Pietrangelo, A., Adams, P. C., de Graaff, B., McLaren, C. E., & Loréal, O. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.16 · Cited by 430
Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
Abdalkader, M., Lampinen, R., Kanninen, K. M., Malm, T. M., & Liddell, J. R. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00466 · Cited by 423
On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver
Theurl, I., Hilgendorf, I., Nairz, M., Tymoszuk, P., Haschka, D., Asshoff, M., He, S., Gerhardt, L. M. S., Holderried, T. A. W., Seifert, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4146 · Cited by 412
miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Luo, M., Wu, L., Zhang, K., Wang, H., Zhang, T., Gutierrez, L., O’Connell, D., Zhang, P., Li, Y., Gao, T., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0053-8 · Cited by 408
NRF2-regulation in brain health and disease: Implication of cerebral inflammation
Sandberg, M., Patil, J., D'Angelo, B., Weber, S. G., & Mallard, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.004 · Cited by 390
Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells
Adedoyin, O., Boddu, R., Traylor, A., Lever, J. M., Bolisetty, S., George, J. F., & Agarwal, A. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00044.2017 · Cited by 368
Cole, S. P. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.609248 · Cited by 361
Modeling the effects of lipid peroxidation during ferroptosis on membrane properties
Agmon, E., Solon, J., Bassereau, P., & Stockwell, B. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-23408-0 · Cited by 344
Ferroptosis and cell death mechanisms in Parkinson's disease
Guiney, S. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Ayton, S. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.004 · Cited by 338
Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins
Rajagopal, A., Rao, A. U., Amigo, J., Tian, M., Upadhyay, S. K., Hall, C., Uhm, S., Mathew, M. K., Fleming, M. D., Paw, B. H., et al. (2008) · Nature · doi:10.1038/nature06934 · Cited by 316
Shin, C.-S., Mishra, P., Watrous, J. D., Carelli, V., D’Aurelio, M., Jain, M., & Chan, D. C. (2017) · Nature Communications · doi:10.1038/ncomms15074 · Cited by 305
Zhang, Y.-H., Wang, D.-W., Xu, S.-F., Zhang, S., Fan, Y.-G., Yang, Y.-Y., Guo, S.-Q., Wang, S., Guo, T., Wang, Z.-Y., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.001 · Cited by 304
Chen, M.-S., Wang, S.-F., Hsu, C.-Y., Yin, P.-H., Yeh, T.-S., Lee, H.-C., & Tseng, L.-M. (2017) · Oncotarget · doi:10.18632/oncotarget.23055 · Cited by 296
The Nrf2/HO‐1 Axis in Cancer Cell Growth and Chemoresistance
Furfaro, A. L., Traverso, N., Domenicotti, C., Piras, S., Moretta, L., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1958174 · Cited by 295
Iron and Alzheimer’s Disease: An Update on Emerging Mechanisms
Lane, D. J. R., Ayton, S., & Bush, A. I. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179944 · Cited by 276
Agyeman, A. S., Chaerkady, R., Shaw, P. G., Davidson, N. E., Visvanathan, K., Pandey, A., & Kensler, T. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1536-9 · Cited by 251
Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain
Yoo, S.-E., Chen, L., Na, R., Liu, Y., Rios, C., Van Remmen, H., Richardson, A., & Ran, Q. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.043 · Cited by 248
The Redox Role of G6PD in Cell Growth, Cell Death, and Cancer
Yang, H.-C., Wu, Y.-H., Yen, W.-C., Liu, H.-Y., Hwang, T.-L., Stern, A., & Chiu, D. T.-Y. (2019) · Cells · doi:10.3390/cells8091055 · Cited by 247
Merry, T. L., & Ristow, M. (2016) · The Journal of Physiology · doi:10.1113/jp271957 · Cited by 246
White, C., Yuan, X., Schmidt, P. J., Bresciani, E., Samuel, T. K., Campagna, D., Hall, C., Bishop, K., Calicchio, M. L., Lapierre, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.005 · Cited by 241
Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism
Huang, J., Tabbi-Anneni, I., Gunda, V., & Wang, L. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00322.2010 · Cited by 228
Deng, Z., Lim, J., Wang, Q., Purtell, K., Wu, S., Palomo, G. M., Tan, H., Manfredi, G., Zhao, Y., Peng, J., et al. (2020) · Autophagy · doi:10.1080/15548627.2019.1644076 · Cited by 228
NCOA4-Mediated Ferritinophagy: A Potential Link to Neurodegeneration
Quiles del Rey, M., & Mancias, J. D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00238 · Cited by 227
Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53
Wang, Y., Yang, L., Zhang, X., Cui, W., Liu, Y., Sun, Q., He, Q., Zhao, S., Zhang, G., Wang, Y., et al. (2019) · EMBO reports · doi:10.15252/embr.201847563 · Cited by 214
Cao, J. Y., Poddar, A., Magtanong, L., Lumb, J. H., Mileur, T. R., Reid, M. A., Dovey, C. M., Wang, J., Locasale, J. W., Stone, E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.043 · Cited by 206
HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRASQ61L cells.
Ye, F., Chai, W., Xie, M., Yang, M., Yan, Y., Cao, L., & Yang, L. (2019) · PubMed · Cited by 202
Daher, B., Parks, S. K., Durivault, J., Cormerais, Y., Baidarjad, H., Tambutte, E., Pouysségur, J., & Vučetić, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3855 · Cited by 200
Lian, G., Gnanaprakasam, J. R., Wang, T., Wu, R., Chen, X., Liu, L., Shen, Y., Yang, M., Yang, J., Chen, Y., et al. (2018) · eLife · doi:10.7554/elife.36158 · Cited by 196
NEET Proteins: A New Link Between Iron Metabolism, Reactive Oxygen Species, and Cancer
Mittler, R., Darash-Yahana, M., Sohn, Y. S., Bai, F., Song, L., Cabantchik, I. Z., Jennings, P. A., Onuchic, J. N., & Nechushtai, R. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7502 · Cited by 186
Lu, K., Alcivar, A. L., Ma, J., Foo, T. K., Zywea, S., Mahdi, A., Huo, Y., Kensler, T. W., Gatza, M. L., & Xia, B. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2204 · Cited by 181
Ishii, T., Warabi, E., & Mann, G. E. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.002 · Cited by 177
Reisman, S. A., Yeager, R. L., Yamamoto, M., & Klaassen, C. D. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn267 · Cited by 174
miR‐9 regulates ferroptosis by targeting glutamic‐oxaloacetic transaminase GOT1 in melanoma
Zhang, K., Wu, L., Zhang, P., Luo, M., Du, J., Gao, T., O'Connell, D., Wang, G., Wang, H., & Yang, Y. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22878 · Cited by 171
Lee, J., Kosaras, B., Del Signore, S. J., Cormier, K., McKee, A., Ratan, R. R., Kowall, N. W., & Ryu, H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0788-5 · Cited by 168
Gong, N.-J., Dibb, R., Bulk, M., van der Weerd, L., & Liu, C. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.02.019 · Cited by 162
To eat or not to eat — the metabolic flavor of ferroptosis
Gao, M., & Jiang, X. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.11.001 · Cited by 158
DeGregorio-Rocasolano, N., Martí-Sistac, O., & Gasull, T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00085 · Cited by 158
Morris, G., Berk, M., Carvalho, A. F., Maes, M. H. J., Walker, A. J., & Puri, B. K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.036 · Cited by 157
Melatonin as a potential modulator of Nrf2
Ahmadi, Z., & Ashrafizadeh, M. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12498 · Cited by 153
Peters, D. G., Connor, J. R., & Meadowcroft, M. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.007 · Cited by 152
Redox-dependent gating of VDAC by mitoNEET
Lipper, C. H., Stofleth, J. T., Bai, F., Sohn, Y., Roy, S., Mittler, R., Nechushtai, R., Onuchic, J. N., & Jennings, P. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908271116 · Cited by 151
Maamoun, H., Benameur, T., Pintus, G., Munusamy, S., & Agouni, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00070 · Cited by 149
Muhammad, H. F. L., van Baak, M. A., Mariman, E. C. M., Sulistyoningrum, D. C., Huriyati, E., Lee, Y. Y., & Muda, W. A. M. W. (2019) · Nutrients · doi:10.3390/nu11010148 · Cited by 148
ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis
Helias, V., Saison, C., Ballif, B. A., Peyrard, T., Takahashi, J., Takahashi, H. K., Tanaka, M., Deybach, J., Puy, H., Gall, M. L., et al. (2012) · Nature Genetics · doi:10.1038/ng.1069 · Cited by 147
Metabolic networks in ferroptosis (Review)
Hao, S., Liang, B., Huang, Q., Dong, S., Wu, Z., He, W., & Shi, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8066 · Cited by 146
MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression
Kabaria, S., Choi, D. C., Chaudhuri, A., Jain, M. R., Li, H., & Junn, E. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.09.010 · Cited by 144
Ferroptosis as a Novel Therapeutic Target for Friedreich’s Ataxia
Cotticelli, M. G., Xia, S. J., Lin, D., Lee, T., Terrab, L., Wipf, P., Huryn, D. M., & Wilson, R. B. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.252759 · Cited by 142
Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1
Zhang, Y., Koppula, P., & Gan, B. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1597506 · Cited by 141
Fillebeen, C., Charlebois, E., Wagner, J., Katsarou, A., Mui, J., Vali, H., Garcia‐Santos, D., Ponka, P., Presley, J. F., & Pantopoulos, K. (2018) · Blood · doi:10.1182/blood-2018-05-850404 · Cited by 138
Iron as a therapeutic target for Parkinson's disease
Moreau, C., Duce, J. A., Rascol, O., Devedjian, J.-C., Berg, D., Dexter, D. T., Cabantchik, Z. I., Bush, A. I., Devos, D., & the FAIRPARK‐II study group (2018) · Movement Disorders · doi:10.1002/mds.27275 · Cited by 137
NaveenKumar, S. K., Hemshekhar, M., Kemparaju, K., & Girish, K. S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.009 · Cited by 134
Becerril-Ortega, J., Bordji, K., Fréret, T., Rush, T., & Buisson, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.019 · Cited by 129
Tanaka, N., Ikeda, Y., Ohta, Y., Deguchi, K., Tian, F., Shang, J., Matsuura, T., & Abe, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.010 · Cited by 124
The Emerging Roles of Ferroptosis in Huntington’s Disease
Mi, Y., Gao, X., Xu, H., Cui, Y., Zhang, Y., & Gou, X. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8518-6 · Cited by 121
Leu, J. I.-J., Murphy, M. E., & George, D. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821277116 · Cited by 119
Novel Hematopoietic Target Genes in the NRF2-Mediated Transcriptional Pathway
Campbell, M. R., Karaca, M., Adamski, K. N., Chorley, B. N., Wang, X., & Bell, D. A. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/120305 · Cited by 118
Modulation of thiol-dependent redox system by metal ionsviathioredoxin and glutaredoxin systems
Ouyang, Y., Peng, Y., Li, J., Holmgren, A., & Lu, J. (2018) · Metallomics · doi:10.1039/c7mt00327g · Cited by 116
SOCS1 regulates senescence and ferroptosis by modulating the expression of p53 target genes
Saint‐Germain, E., Mignacca, L., Vernier, M., Bobbala, D., Ilangumaran, S., & Ferbeyre, G. (2017) · Aging · doi:10.18632/aging.101306 · Cited by 113
Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.11.005 · Cited by 109
Hou, L., Huang, R., Sun, F., Zhang, L., & Wang, Q. (2019) · Toxicology · doi:10.1016/j.tox.2019.02.011 · Cited by 109
Bea, F., Hudson, F. N., Chait, A., Kavanagh, T. J., & Rosenfeld, M. E. (2003) · Circulation Research · doi:10.1161/01.res.0000059561.65545.16 · Cited by 106
Cong, L., Dong, X., Wang, Y., Deng, Y., Li, B., & Dai, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.039 · Cited by 106
An, H., Zeng, X., Niu, T., Li, G., Yang, J., Zheng, L., Zhou, W., Liu, H., Zhang, M., Huang, D., et al. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.01.008 · Cited by 102
Glutathione synthetase deficiency
NJÅLSSON, R. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5163-7 · Cited by 97
Ferrosenescence: The iron age of neurodegeneration?
Sfera, A., Bullock, K., Price, A. I., Inderias, L., & Osorio, C. P. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.11.012 · Cited by 96
Wang, Q., Li, W.-X., Dai, S.-X., Guo, Y.-C., Han, F.-F., Zheng, J.-J., Li, G.-H., & Huang, J.-F. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161032 · Cited by 88 · cited 1×
“…(Tanaka et al., 2011; Dang et al., 2012; Sandberg et al., 2014), and numerous evidence suggests that Nrf2 plays an important role in the development and treatment of neurodegenerative diseases (Wang et al., 2017; Deng et al., 2019; Jang et al., 2019; Pachón-Angona et al., 2019; Wei et al., 2019).”
BackgroundNavarro, E., González‐Lafuente, L., Pérez-Liébana, I., Buendía, I., López-Bernardo, E., Sánchez‐Ramos, C., Priéto, I., Cuadrado, A., Satrústegui, J., Cadenas, S., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6698 · Cited by 87
Anthonymuthu, T. S., Kenny, E., Shrivastava, I. H., Tyurina, Y. Y., Hier, Z. E., Ting, H.-C., Dar, H. H., Tyurin, V. A., Nesterova, A., Amoscato, A. A., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b09913 · Cited by 87
Zille, M., Kumar, A., Kundu, N., Bourassa, M. W., Wong, V. S. C., Willis, D. E., Karuppagounder, S. S., & Ratan, R. R. (2019) · eNeuro · doi:10.1523/eneuro.0263-18.2019 · Cited by 86
Iron Exposure and the Cellular Mechanisms Linked to Neuron Degeneration in Adult Mice
Li, L.-B., Chai, R., Zhang, S., Xu, S., Zhang, Y., Li, H., Fan, Y., & Guo, C. (2019) · Cells · doi:10.3390/cells8020198 · Cited by 86
Ferroptosis – An iron- and disorder-dependent programmed cell death
Djulbegovic, M. B., & Uversky, V. N. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.05.221 · Cited by 84
The Neuropathology of Neurodegeneration with Brain Iron Accumulation
Kruer, M. C. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00009-0 · Cited by 79
Deng, Y. L., Zhu, J., Mi, C., Xu, B., Jiao, C., Li, Y., Xu, D., Liu, W., & Xu, Z. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9489-5 · Cited by 78
Kabiraj, P., Valenzuela, C. A., Marin, J. E., Ramirez, D. A., Méndez, L., Hwang, M. S., Varela-Ramírez, A., Fénelon, K., Narayan, M., & Skouta, R. (2015) · The Protein Journal · doi:10.1007/s10930-015-9629-7 · Cited by 77
Prigge, J. R., Coppo, L., Martin, S. S., Ogata, F. T., Miller, C. G., Bruschwein, M. D., Orlicky, D. J., Shearn, C. T., Kundert, J. A., Lytchier, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.019 · Cited by 77
Cataneo, A. H. D., Tomiotto‐Pellissier, F., Miranda-Sapla, M. M., Assolini, J. P., Panis, C., Kian, D., Yamauchi, L. M., Simão, A. N. C., Casagrande, R., Pinge‐Filho, P., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108745 · Cited by 77
Xu, B., Lefringhouse, J., Liu, Z., Piecoro, D. W., Baldwin, L. A., Ou, C., Chen, L., Napier, D. L., Chaiswing, L., Brewer, L. D., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2016.86 · Cited by 76
Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice
Li, H., Choesang, T., Bao, W., Chen, H., Feola, M., Garcia‐Santos, D., Li, J., Sun, S., Follenzi, A., Pham, P., et al. (2017) · Blood · doi:10.1182/blood-2016-09-742387 · Cited by 76
Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage
Chen‐Roetling, J., & Regan, R. F. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161027150616 · Cited by 72
Jang, M., Choi, J. H., Chang, Y., Lee, S. J., Nah, S.-Y., & Cho, I. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.03.001 · Cited by 71
Carbone, M., & Melino, G. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-2453 · Cited by 69
Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease
Liddell, J. R., & White, A. R. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.016 · Cited by 67
Postmortem T 2 * - Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer’s Disease
Bulk, M., Kenkhuis, B., van der Graaf, L. M., Goeman, J. J., Natté, R., & van der Weerd, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180317 · Cited by 65
Ferrochelatase is a therapeutic target for ocular neovascularization
Basavarajappa, H. D., Sulaiman, R. S., Qi, X., Shetty, T., Pasha, S. P. B. S., Sishtla, K. L., Lee, B., Quigley, J., Alkhairy, S., Briggs, C. M., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606561 · Cited by 63
Dang, J., Brandenburg, L., Rosen, C., Fragoulis, A., Kipp, M., Pufe, T., Beyer, C., & Wruck, C. J. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9645-9 · Cited by 61
Tomiotto‐Pellissier, F., Alves, D. R., Miranda-Sapla, M. M., de Morais, S. M., Assolini, J. P., Bortoleti, B. T. D. S., Gonçalves, M. D., Cataneo, A. H. D., Kian, D., Madeira, T. B., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.12.083 · Cited by 60
ABCB6, an ABC Transporter Impacting Drug Response and Disease
Boswell-Casteel, R. C., Fukuda, Y., & Schuetz, J. D. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0165-6 · Cited by 55
Naringenin targets on astroglial Nrf2 to support dopaminergic neurons
Wang, G., Zhang, B., He, X., Li, D., Shi, J., & Zhang, F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.043 · Cited by 55
Interactions between mitoNEET and NAF-1 in cells
Karmi, O., Holt, S. H., Song, L., Tamir, S., Luo, Y., Bai, F., Adenwalla, A., Darash‐Yahana, M., Sohn, Y., Jennings, P. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175796 · Cited by 54
Buijs, M., Doan, N. T., van Rooden, S., Versluis, M. J., van Lew, B., Milles, J., van der Grond, J., & van Buchem, M. A. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.09.005 · Cited by 52
Chillappagari, S., Venkatesan, S., Garapati, V., Mahavadi, P., Munder, A., Seubert, A., Sarode, G. V., Günther, A., Schmeck, B., Tümmler, B., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00167.2014 · Cited by 46
MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53
Wang, Y., Wang, G., Tan, X., Ke, K., Zhao, B., Cheng, N., Dang, Y., Liao, N., Wang, F., Zheng, X., et al. (2019) · Oncogenesis · doi:10.1038/s41389-019-0176-5 · Cited by 46
Cryptotanshinone Attenuates Inflammatory Response of Microglial Cells via the Nrf2/HO-1 Pathway
Zhou, Y., Wang, X., Ying, W., Wu, D., & Zhong, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00852 · Cited by 42
Dimethyl Fumarate Induces Glutathione Recycling by Upregulation of Glutathione Reductase
Hoffmann, C., Dietrich, M., Herrmann, A.-K., Schacht, T., Albrecht, P., & Methner, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6093903 · Cited by 39
Alterations in System xc− Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2
Carpi-Santos, R., & Calaza, K. D. C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0961-8 · Cited by 39
Hirata, Y., Iwasaki, T., Makimura, Y., Okajima, S., Oh‐hashi, K., & Takemori, H. (2019) · Toxicology · doi:10.1016/j.tox.2019.02.012 · Cited by 39
Ferrous Iron Induces Nrf2 Expression in Mouse Brain Astrocytes to Prevent Neurotoxicity
Cui, Z., Zhong, Z., Yang, Y., Wang, B., Sun, Y., Sun, Q., Yang, G., & Bian, L. (2016) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21803 · Cited by 38
Chen, X., Xi, Z., Liang, H., Sun, Y., Zhong, Z., Wang, B., Bian, L., & Sun, Q. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00760 · Cited by 37
de Oliveira, M. R., de Souza, I. C. C., & Fürstenau, C. R. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108728 · Cited by 35
van Raaij, S. E. G., Masereeuw, R., Swinkels, D. W., & van Swelm, R. P. L. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.06.1218 · Cited by 34
Zhang, Y., Ding, Y. P., Lu, T., Zhang, Y., Xu, N., McBride, D. W., Tang, J., & Zhang, J. H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1155-z · Cited by 29
Hrg1 promotes heme-iron recycling during hemolysis in the zebrafish kidney
Zhang, J., Chambers, I. G., Yun, S., Phillips, J. D., Krause, M., & Hamza, I. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007665 · Cited by 29
Feng, L., Cui, L., Yu, D., Hao, H., Liu, Y., Zhao, X., Pang, Y., Zhu, H., & Du, W. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27497 · Cited by 29
Kweider, N., Wruck, C. J., & Rath, W. H. (2013) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0033-1360133 · Cited by 28
Wei, P., Lee‐Chen, G., Chen, C., Wu, Y., Chen, Y.-J., Lin, J.-L., Lo, Y., Yao, C., & Chang, K. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5074367 · Cited by 28
Gene Polymorphisms in the Heme Degradation Pathway and Outcome of Severe Human Sepsis
Sponholz, C., Huse, K., Kramer, M., Giamarellos‐Bourboulis, E. J., Claus, R. A., Kern, A., Engel, C., Kuhnt, E., Kiehntopf, M., Routsi, C., et al. (2012) · Shock · doi:10.1097/shk.0b013e31826ae951 · Cited by 27
de Oliveira, M. R., Brasil, F. B., & Fürstenau, C. R. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1027-0 · Cited by 26
Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Kempuraj, D., Dubova, I., Saeed, D., Zahoor, H., Premkumar, K., Zaheer, S. A., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09833-6 · Cited by 26
Pachón-Angona, I., Martin, H., Chhor, S., Oset‐Gasque, M. J., Refouvelet, B., Marco, J. L., & Ismaïli, L. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0191 · Cited by 24
Kim, V. Y., Batty, A. J., Li, J., Kirk, S. G., Crowell, S. A., Jin, Y., Tang, J., Zhang, J., Rogers, L. K., Deng, H., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1701686 · Cited by 22
Song, H., Wang, M., & Xin, T. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28945 · Cited by 19
Ono, K., Furugen, A., Kurosawa, Y., Jinno, N., Narumi, K., Kobayashi, M., & Iseki, K. (2018) · Placenta · doi:10.1016/j.placenta.2018.11.010 · Cited by 17
Shin, E.-J., Han, E. J., Han, H.-J., Jung, K., Heo, S., Kim, E.-A. L., Kim, K., Kim, S.-C., Seo, M.-J., Kwak, I., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8023-5_58 · Cited by 5
Cited by
Li, Y., Feng, D., Wang, Z., Zhao, Y., Sun, R., Tian, D., Liu, D., Zhang, F., Ning, S., Yao, J., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0299-4 · Cited by 872
Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
Mahoney-Sánchez, L., Bouchaoui, H., Ayton, S., Devos, D., Duce, J. A., & Devedjian, J.-C. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101890 · Cited by 553
Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway
Dang, R., Wang, M., Li, X., Wang, H., Liu, L., Wu, Q., Zhao, J., Ji, P., Zhong, L., Licinio, J., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02400-6 · Cited by 520
Wang, X., Chen, X., Zhou, W., Men, H., Bao, T., Sun, Y., Wang, Q., Tan, Y., Keller, B. B., Tong, Q., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.005 · Cited by 510
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Metadata
- Authors
- Song, X., & Long, D.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-04-21
- Volume
- 14
- Pages
- 267-267
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W3020593143
- Cited by
- 577
- References
- 180
- FWCI
- 36.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.